Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial

ClinicalTrials.gov ID: NCT00347360

Public ClinicalTrials.gov record NCT00347360. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Double-Dummy, Parallel Group, Factorial Design Trial to Assess the Efficacy and Safety of up to Six Weeks Treatment With 20mg, 40mg, or 80mg QD Doses of Carvedilol Controlled Release Formulation (COREG CR) or 10mg, 20mg, or 40mg QD Doses of Lisinopril (Zestril) or a Combination of One of the Doses of Each Medication

Study identification

NCT ID
NCT00347360
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
654 participants

Conditions and interventions

Conditions

Interventions

  • lisinopril Drug
  • carvedilol controlled release formulation Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2006
Primary completion
Mar 31, 2008
Completion
Mar 31, 2008
Last update posted
Dec 25, 2016

2006 – 2008

United States locations

U.S. sites
151
U.S. states
36
U.S. cities
134
Facility City State ZIP Site status
GSK Investigational Site Anniston Alabama 36207
GSK Investigational Site Birmingham Alabama 35215
GSK Investigational Site Birmingham Alabama 35216
GSK Investigational Site Birmingham Alabama 35235
GSK Investigational Site Birmingham Alabama 35242
GSK Investigational Site Haleyville Alabama 35565
GSK Investigational Site Mobile Alabama 36617
GSK Investigational Site Muscle Shoals Alabama 35662
GSK Investigational Site Chandler Arizona 85225
GSK Investigational Site Gilbert Arizona 85296
GSK Investigational Site Glendale Arizona 85308
GSK Investigational Site Mesa Arizona 85206
GSK Investigational Site Phoenix Arizona 85023
GSK Investigational Site Phoenix Arizona 85032
GSK Investigational Site Phoenix, Arizona Arizona 86106
GSK Investigational Site Scottsdale Arizona 85251
GSK Investigational Site Scottsdale Arizona 85260
GSK Investigational Site Sun City Arizona 85351
GSK Investigational Site Tucson Arizona 85712
GSK Investigational Site Tucson Arizona 85741
GSK Investigational Site Little Rock Arkansas 72204
GSK Investigational Site Searcy Arkansas 72143
GSK Investigational Site Beuna Park California 90620
GSK Investigational Site Beverly Hills California 90211
GSK Investigational Site Burbank California 91505
GSK Investigational Site Carlsbad California 92008
GSK Investigational Site Fountain Valley California 92708
GSK Investigational Site Fresno California 93703
GSK Investigational Site Loma Linda California 92354
GSK Investigational Site Mission Viejo California 92691
GSK Investigational Site Pico Rivera California 90660
GSK Investigational Site Rancho Cordova California 95670
GSK Investigational Site San Diego California 92117
GSK Investigational Site San Diego California 92128
GSK Investigational Site Santa Ana California 92705
GSK Investigational Site Vista California 92084
GSK Investigational Site Walnut Creek California 94598
GSK Investigational Site Colorado Springs Colorado 80904
GSK Investigational Site Denver Colorado 80206
GSK Investigational Site Wilmington Delaware 19805
GSK Investigational Site Washington D.C. District of Columbia 20017
GSK Investigational Site Coral Gables Florida 33134
GSK Investigational Site Hialeah Florida 33013
GSK Investigational Site Hollywood Florida 33023
GSK Investigational Site Jacksonville Florida 32205
GSK Investigational Site Jacksonville Beach Florida 32250
GSK Investigational Site Miami Florida 33156
GSK Investigational Site Miami Florida 33169
GSK Investigational Site Palm Harbor Florida 34684
GSK Investigational Site Pembroke Pines Florida 33024
GSK Investigational Site Pembroke Pines Florida 33027
GSK Investigational Site Sarasota Florida 34239
GSK Investigational Site West Palm Beach Florida 33409
GSK Investigational Site Gainesville Georgia 30501
GSK Investigational Site Marietta Georgia 30066
GSK Investigational Site Sandersville Georgia 31082
GSK Investigational Site Savannah Georgia 31406
GSK Investigational Site Aurora Illinois 60504
GSK Investigational Site Chicago Illinois 60607
GSK Investigational Site Chicago Illinois 60610
GSK Investigational Site Melrose Park Illinois 60160
GSK Investigational Site Avon Indiana 46123
GSK Investigational Site Bloomington Indiana 47102
GSK Investigational Site Fort Wayne Indiana 46804
GSK Investigational Site Indianapolis Indiana 46250
GSK Investigational Site Ames Iowa 50010
GSK Investigational Site Wichita Kansas 67205
GSK Investigational Site Slidell Louisiana 70458
GSK Investigational Site Springfield Massachusetts 01103
GSK Investigational Site Taunton Massachusetts 02780.
GSK Investigational Site Bingham Farms Michigan 48025
GSK Investigational Site Brooklyn Center Minnesota 55430
GSK Investigational Site Missoula Montana 59808
GSK Investigational Site O Fallon Montana 63366
GSK Investigational Site Omaha Nebraska 68131
GSK Investigational Site Las Vegas Nevada 89016
GSK Investigational Site Las Vegas Nevada 89119
GSK Investigational Site Las Vegas Nevada 89128
GSK Investigational Site Cherry Hill New Jersey 08034
GSK Investigational Site Edison New Jersey 08817
GSK Investigational Site Ridgewood New Jersey 7450
GSK Investigational Site Voorhees Township New Jersey 08043
GSK Investigational Site Albuquerque New Mexico 87102
GSK Investigational Site Brooklyn New York 11203
GSK Investigational Site Buffalo New York 14215
GSK Investigational Site Kingston New York 12401
GSK Investigational Site Lewinston New York 14092
GSK Investigational Site Tonawanda New York 14150-1810
GSK Investigational Site Asheville North Carolina 28801
GSK Investigational Site Charlotte North Carolina 28211
GSK Investigational Site High Point North Carolina 27262
GSK Investigational Site Raleigh North Carolina 27615
GSK Investigational Site Fargo North Dakota 58103
GSK Investigational Site Cincinnati Ohio 45219
GSK Investigational Site Cincinnati Ohio 45236
GSK Investigational Site Cleveland Ohio 44106
GSK Investigational Site Cleveland Ohio 44195
GSK Investigational Site Dayton Ohio 45406
GSK Investigational Site Oklahoma City Oklahoma 73103
GSK Investigational Site Oklahoma City Oklahoma 73112
GSK Investigational Site Tulsa Oklahoma 74104
GSK Investigational Site Eugene Oregon 97401
GSK Investigational Site Beaver Pennsylvania 15009
GSK Investigational Site Doylestown Pennsylvania 18901
GSK Investigational Site Erie Pennsylvania 16504
GSK Investigational Site Havertown Pennsylvania 19083
GSK Investigational Site Landsdale Pennsylvania 19446
GSK Investigational Site Leetsdale Pennsylvania 15056
GSK Investigational Site Philadelphia Pennsylvania 19152
GSK Investigational Site Philadelphia Pennsylvania 19154
GSK Investigational Site Warminster Pennsylvania 18974
GSK Investigational Site West Chester Pennsylvania 19380
GSK Investigational Site Beaufort South Carolina 29906
GSK Investigational Site Charleston South Carolina 29403
GSK Investigational Site Columbia South Carolina 29201
GSK Investigational Site Gaffney South Carolina 29340
GSK Investigational Site Greer South Carolina 29651
GSK Investigational Site Hilton Head Island South Carolina 29926
GSK Investigational Site Manning South Carolina 29102
GSK Investigational Site Simpsonville South Carolina 29681
GSK Investigational Site Spartanburg South Carolina 29303
GSK Investigational Site Sumter South Carolina 29150
GSK Investigational Site Taylors South Carolina 29687
GSK Investigational Site Union South Carolina 29309
GSK Investigational Site Clarksville Tennessee 37043
GSK Investigational Site Jackson Tennessee 38305
GSK Investigational Site Johnson City Tennessee 37601
GSK Investigational Site Nashville Tennessee 37203
GSK Investigational Site Selmer Tennessee 38375
GSK Investigational Site Arlington Texas 76014
GSK Investigational Site Austin Texas 78705
GSK Investigational Site Georgetown Texas 78626
GSK Investigational Site Grand Prairie/Texas Texas 5052
GSK Investigational Site Houston Texas 77081
GSK Investigational Site Longview Texas 75605
GSK Investigational Site San Antonio Texas 78224
GSK Investigational Site San Antonio Texas 78229
GSK Investigational Site Sugar Land Texas 77479
GSK Investigational Site Temple Texas 76502
GSK Investigational Site Waco Texas 76712
GSK Investigational Site Murray Utah 84107
GSK Investigational Site Salt Lake City Utah 84102
GSK Investigational Site Sandy City Utah 84094
GSK Investigational Site Arlington Virginia 22205
GSK Investigational Site Burke Virginia 22015
GSK Investigational Site Chester Virginia 23836
GSK Investigational Site Fairfax Virginia 22030
GSK Investigational Site Manassas Virginia 20110
GSK Investigational Site Spokane Washington 99206
GSK Investigational Site Tacoma Washington 98405
GSK Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00347360, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 25, 2016 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00347360 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →